Analysis of pediatric pre-prescription review orders based on PCNE classification system
- VernacularTitle:基于PCNE分类系统的儿科前置审核医嘱分析
- Author:
Anle SHEN
1
,
2
;
Peiqi WANG
1
,
3
;
Tao XU
1
;
Jia LUO
1
;
Xuexian WANG
1
;
Shunguo ZHANG
1
;
Zhiling LI
1
Author Information
1. Dept. of Pharmacy，Shanghai Children’s Medical Center，Shanghai Jiao Tong University School of Medicine，Shanghai 200127，China
2. Dept. of Pharmacy，Shanghai Children’s Medical Center Hainan Hospital，Shanghai Jiao Tong University School of Medicine，Hainan Sanya 572000，China
3. School of Pharmacy，Shanghai University of Medicine & Health Sciences，Shanghai 201318，China
- Publication Type:Journal Article
- Keywords:
PCNE classification system;
drug-related
- From:
China Pharmacy
2025;36(3):351-355
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide reference for improving the pre-prescription review system and reducing the occurrence of medication error by analyzing the drug-related problems （DRPs） in the pre-prescription review orders of pediatric outpatient clinics using the Pharmaceutical Care Network Europe （PCNE） classification system. METHODS The data of pre-prescription review orders were retrospectively collected from outpatient department of Shanghai Children’s Medical Center， Shanghai Jiao Tong University School of Medicine from July 2022 to June 2023； DRPs in the pre-prescription review orders were classified and summarized by using the PCNE classification system （version 9.1）， and then analyzed in terms of types and causes of issues， and the acceptance of interventions. RESULTS A total of 66 017 DRPs orders were included， involving 41 165 patients. The proportion of DRPs orders in children aged ≤5 years old was the highest （58.25%）， followed by children aged 6-12 years old （33.52%）； the department with the highest proportion of DRPs was internal medicine of pediatrics department （71.41%）； the department with the highest incidence of DRPs was thoracic surgery department （9.73%）； top three drug categories of DRPs orders were systemic anti- infective drugs （25.26%）， Chinese patent medicines （24.74%） and respiratory drugs （22.38%）. Referring to PCNE classification system， the types of DRPs mainly focused on treatment safety （64.86%）； the reasons of DRPs orders mainly focused on dose selection （82.09%）， of which 41.26% were due to excessive drug dosage； 92.13% of interventions could be accepted and fully executed by doctors. CONCLUSIONS DRPs orders identified by the pre-prescription review system can be effectively analyzed by using PCNE classification system. Pharmacists should focus on medication use in children aged ≤5 years old， update and develop personalized prescription review rules timely， and meet the rational needs of clinical medication for children.
